JATT II Acquisition Corp (JATT)
JATT II Acquisition will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
6,000,000
Deal Size
$60.00M
Company Description
JATT II Acquisition is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
We intend to focus our search on healthcare and healthcare-related businesses, with a primary emphasis on biotechnology and broader life sciences.
JATT II Acquisition Corp
| Country | United States |
| Founded | 2026 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Dr. Someit Sidhu |
Contact Details
Address: 153 Central Avenue, C/O 56 Westfield, NJ 07091 United States | |
| Phone | 201-688-0364 |
Stock Details
| Ticker Symbol | JATT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 2112446 |
| CUSIP Number | G50752107 |
| ISIN Number | KYG507521071 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. Someit Sidhu | Chairman, Director, and Chief Executive Officer |
| Nicholas Fernandez | Chief Financial Officer |
| Verender S. Badial | Director Nominee |
| Christopher Staral | Director Nominee |
| Dr. Arjun Goyal | Director Nominee |
| Dr. Jonathon Kluft | Director Nominee |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 2, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Mar 13, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |